Myeloperoxidase binds to and kills Entamoeba histolytica trophozoites

Parasite Immunology

Volumn 33, Issue 5, 2011, Pages 255-264

  Pacheco Yepez J ^a   Rivera Aguilar, V ^b   Barbosa Cabrera, E ^c   Rojas Hernandez S ^c   Jarillo Luna, R A ^c   Campos Rodriguez R ^c  

^a UNIVERSIDAD LA SALLE   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Amebicidal activity; E. histolytica; Hydrogen peroxide; Myeloperoxidase; Neutrophil

Indexed keywords

GLYCOGEN; HYDROGEN PEROXIDE; MYELOPEROXIDASE;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL MEMBRANE; CELL NUCLEUS; CELL STRUCTURE; CONTROLLED STUDY; ENTAMOEBA HISTOLYTICA; ENZYME ACTIVITY; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; TROPHOZOITE;

ANIMALS; ANTIPROTOZOAL AGENTS; CELL SURVIVAL; CRICETINAE; ENTAMOEBA HISTOLYTICA; MALE; MESOCRICETUS; NEUTROPHILS; PEROXIDASE; PROTEIN BINDING; TROPHOZOITES;

CRICETINAE; ENTAMOEBA HISTOLYTICA;

EID: 79953797944     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2010.01275.x     Document Type: Article

References (58)

1. Ivory C, Kammanadiminti S & Chadee K. Innate resistance to Entamoeba histolytica in murine models. Trends Parasitol 2007; 23: 46-48.
2. Guo X, Houpt E & Petri WA Jr. Crosstalk at the initial encounter: interplay between host defense and ameba survival strategies. Curr Opin Immunol 2007; 19: 376-384.
3. Campos-Rodriguezp R & Jarillo-Luna A. The pathogenicity of Entamoeba histolytica is related to the capacity of evading innate immunity. Parasite Immunol 2005; 27: 1-8.
4. Prathap K & Gilman R. The histopathology of acute intestinal amebiasis. A rectal biopsy study. Am J Pathol 1970; 60: 229-246.
5. Tsutsumi V, Mena-Lopez R, Anaya-Velazquez F & Martinez-Palomo A. Cellular bases of experimental amebic liver abscess formation. Am J Pathol 1984; 117: 81-91.
6. Seydel KB, Li E, Zhang Z & Stanley SL Jr. Epithelial cell-initiated inflammation plays a crucial role in early tissue damage in amebic infection of human intestine. Gastroenterology 1998; 115: 1446-1453.
7. Velazquez C, Shibayama-Salas M, Aguirre-Garcia J, Tsutsumi V & Calderon J. Role of neutrophils in innate resistance to Entamoeba histolytica liver infection in mice. Parasite Immunol 1998; 20: 255-262.
8. Jarillo-Luna RA, Campos-Rodriguez R & Tsutsumi V. Entamoeba histolytica: immunohistochemical study of hepatic amoebiasis in mouse. Neutrophils and nitric oxide as possible factors of resistance. Exp Parasitol 2002; 101: 40-56.
9. Asgharpour A, Gilchrist C, Baba D, Hamano S & Houpt E. Resistance to intestinal Entamoeba histolytica infection is conferred by innate immunity and Gr-1+ cells. Infect Immun 2005; 73: 4522-4529.
10. Stanley SL. Pathophysiology of amoebiasis. Trends Parasitol 2001; 17: 280-285.
11. Pérez-Tamayo RBI, Montfort I & Pérez-Montfort R. Pathobiology of amebiasis. In Krestchmer RR (ed.): Amebiasis: Infection and Disease by Entamoeba histolytica. Boca Raton, FL, CRC Press, 1990: 123-157.
12. Ghadirian E, Somerfield SD & Kongshavn PA. Susceptibility of Entamoeba histolytica to oxidants. Infect Immun 1986; 51: 263-267.
13. Seydel KB, Smith SJ & Stanley SL Jr. Innate immunity to amebic liver abscess is dependent on gamma interferon and nitric oxide in a murine model of disease. Infect Immun 2000; 68: 400-402.
14. Murray HW, Aley SB & Scott WA. Susceptibility of Entamoeba histolytica to oxygen intermediates. Mol Biochem Parasitol 1981; 3: 381-391.
15. Choi MH, Sajed D, Poole L, et al. An unusual surface peroxiredoxin protects invasive Entamoeba histolytica from oxidant attack. Mol Biochem Parasitol 2005; 143: 80-89.
16. Salata RA, Pearson RD & Ravdin JI. Interaction of human leukocytes and Entamoeba histolytica. Killing of virulent amebae by the activated macrophage. J Clin Invest 1985; 76: 491-499.
17. Jarumilinta R & Kradolfer F. The toxic effect of Entamoeba histolytica on leucocytes. Ann Trop Med Parasitol 1964; 58: 375-381.
18. Aratani Y, Koyama H, Nyui S, Suzuki K, Kura F & Maeda N. Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun 1999; 67: 1828-1836.
19. Klebanoff SJ. Myeloperoxidase. Proc Assoc Am Physicians 1999; 111: 383-389.
20. Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol 2005; 77: 598-625.
21. Hampton MB, Kettle AJ & Winterbourn CC. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 1998; 92: 3007-3017.
22. Shibayama M, Rivera-Aguilar V, Barbosa-Cabrera E, et al. Innate immunity prevents tissue invasion by Entamoeba histolytica. Can J Microbiol 2008; 54: 1032-1042.
23. Diamond LS, Harlow DR & Cunnick CC. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg 1978; 72: 431-432.
24. Gilbert RO, Elia G, Beach DH, Klaessig S & Singh BN. Cytopathogenic effect of Trichomonas vaginalis on human vaginal epithelial cells cultured in vitro. Infect Immun 2000; 68: 4200-4206.
25. Taylor KL, Guzman GS, Pohl J & Kinkade JM Jr. Distinct chromatographic forms of human hemi-myeloperoxidase obtained by reductive cleavage of the dimeric enzyme. Evidence for subunit heterogeneity. J Biol Chem 1990; 265: 15938-15946.
26. Cooray R, Petersson CG & Gronvik KO. Preparation and characterization of monoclonal antibodies against bovine myeloperoxidase. Vet Immunol Immunopathol 1995; 46: 211-221.
27. Homma T, Suzuki K, Kudo Y, et al. Preparation and characterization of monoclonal antibodies against human myeloperoxidase. Arch Biochem Biophys 1989; 273: 189-196.
28. Morishita K, Asano S, Fujii H, Yokota J, Kodo H & Miwa S. Biochemical comparison of myeloperoxidase of leukemic myeloblasts and normal neutrophilic granulocytes. J Appl Biochem 1984; 6: 271-277.
29. Nauseef WM, Root RK & Malech HL. Biochemical and immunologic analysis of hereditary myeloperoxidase deficiency. J Clin Invest 1983; 71: 1297-1307.
30. Andrews PC & Krinsky NI. The reductive cleavage of myeloperoxidase in half, producing enzymically active hemi-myeloperoxidase. J Biol Chem 1981; 256: 4211-4218.
31. Pember SO, Shapira R & Kinkade JM Jr. Multiple forms of myeloperoxidase from human neutrophilic granulocytes: evidence for differences in compartmentalization, enzymatic activity, and subunit structure. Arch Biochem Biophys 1983; 221: 391-403.
32. Miyasaki KT, Wilson ME, Cohen E, Jones PC & Genco RJ. Evidence for and partial characterization of three major and three minor chromatographic forms of human neutrophil myeloperoxidase. Arch Biochem Biophys 1986; 246: 751-764.
33. Miyasaki KT, Zambon JJ, Jones CA & Wilson ME. Role of high-avidity binding of human neutrophil myeloperoxidase in the killing of Actinobacillus actinomycetemcomitans. Infect Immun 1987; 55: 1029-1036.
34. 2-chloride antimicrobial system: a possible in vivo mechanism of action. Infect Immun 1970; 2: 414-418.
35. Wright CD, Bowie JU, Gray GR & Nelson RD. Candidacidal activity of myeloperoxidase: mechanisms of inhibitory influence of soluble cell wall mannan. Infect Immun 1983; 42: 76-80.
36. 2-Cl-system. J Infect Dis 1978; 137: 481-485.
37. de Mendez I, Daniel H, Bignon J & Lambre CR. Peroxidase activities in the hamster bronchoalveolar lining fluid: modifications induced by exposure to silica dust. Exp Lung Res 1989; 15: 681-694.
38. Andersen MR, Atkin CL & Eyre HJ. Intact form of myeloperoxidase from normal human neutrophils. Arch Biochem Biophys 1982; 214: 273-283.
39. Svensson BE, Domeij K, Lindvall S & Rydell G. Peroxidase and peroxidase-oxidase activities of isolated human myeloperoxidases. Biochem J 1987; 242: 673-680.
40. Felberg NT & Schultz J. Evidence that myeloperoxidase is composed of isoenzymes. Arch Biochem Biophys 1972; 148: 407-413.
41. Yamada M, Mori M & Sugimura T. Purification and characterization of small molecular weight myeloperoxidase from human promyelocytic leukemia HL-60 cells. Biochemistry 1981; 20: 766-771.
42. Ikeda-Saito M, Shelley DA, Lu L, Booth KS, Caughey WS & Kimura S. Salicylhydroxamic acid inhibits myeloperoxidase activity. J Biol Chem 1991; 266: 3611-3616.
43. Jerlich A, Fritz G, Kharrazi H, et al. Comparison of HOCl traps with myeloperoxidase inhibitors in prevention of low density lipoprotein oxidation. Biochim Biophys Acta 2000; 1481: 109-118.
44. Davies B & Edwards SW. Inhibition of myeloperoxidase by salicylhydroxamic acid. Biochem J 1989; 258: 801-806.
45. Molina HA, Kierszenbaum F, Hamann KJ & Gleich GJ. Toxic effects produced or mediated by human eosinophil granule components on Trypanosoma cruzi. Am J Trop Med Hyg 1988; 38: 327-334.
46. McLaren DJ, Mackenzie CD & Ramalho-Pinto FJ. Ultrastructural observations on the in vitro interaction between rat eosinophils and some parasitic helminths (Schistosoma mansoni, Trichinella spiralis and Nippostrongylus brasiliensis). Clin Exp Immunol 1977; 30: 105-118.
47. Locksley RM, Wilson CB & Klebanoff SJ. Role for endogenous and acquired peroxidase in the toxoplasmacidal activity of murine and human mononuclear phagocytes. J Clin Invest 1982; 69: 1099-1111.
48. Dale DC, Boxer L & Liles WC. The phagocytes: neutrophils and monocytes. Blood 2008; 112: 935-945.
49. Bruchhaus I & Tannich E. Induction of the iron-containing superoxide dismutase in Entamoeba histolytica by a superoxide anion-generating system or by iron chelation. Mol Biochem Parasitol 1994; 67: 281-288.
50. Bruchhaus I & Tannich E. Identification of an Entamoeba histolytica gene encoding a protein homologous to prokaryotic disulphide oxidoreductases. Mol Biochem Parasitol 1995; 70: 187-191.
51. Bruchhaus I, Richter S & Tannich E. Recombinant expression and biochemical characterization of an NADPH:flavin oxidoreductase from Entamoeba histolytica. Biochem J 1998; 330(Pt 3): 1217-1221.
52. Akbar MA, Chatterjee NS, Sen P, et al. Genes induced by a high-oxygen environment in Entamoeba histolytica. Mol Biochem Parasitol 2004; 133: 187-196.
53. Campos-Rodriguez R, Jarillo-Luna RA, Larsen BA, Rivera-Aguilar V & Ventura-Juarez J. Invasive amebiasis: a microcirculatory disorder? Med Hypotheses 2009; 73: 687-697.
54. Santi-Rocca J, Rigothier MC & Guillen N. Host-microbe interactions and defense mechanisms in the development of amoebic liver abscesses. Clin Microbiol Rev 2009; 22: 65-75, Table of Contents.
55. Espinosa-Cantellano M, Gonzales-Robles A, Chavez B, et al. Entamoeba dispar: ultrastructure, surface properties and cytopathic effect. J Eukaryot Microbiol 1998; 45: 265-272.
56. Trissl D, Martinez-Palomo A, Arguello C, de la Torre M & de la Hoz R. Surface properties related to concanavalin A-induced agglutination. A comparative study of several Entamoeba strains. J Exp Med 1977; 145: 652-665.
57. Espinosa-Cantellano M & Martinez-Palomo A. Pathogenesis of intestinal amebiasis: from molecules to disease. Clin Microbiol Rev 2000; 13: 318-331.
58. Jong EC, Chi EY & Klebanoff SJ. Human neutrophil-mediated killing of schistosomula of Schistosoma mansoni: augmentation by schistosomal binding of eosinophil peroxidase. Am J Trop Med Hyg 1984; 33: 104-115.